Volume 51, Issue 2 pp. 380-392

Characterization of Jk(a+weak): a new blood group phenotype associated with an altered JK*01 allele

Elisabet S. Wester

Elisabet S. Wester

From the Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund; and the Department of Clinical Immunology and Transfusion Medicine, University and Regional Laboratories Region Skåne, Lund, Sweden.

Search for more papers by this author
Jill R. Storry

Jill R. Storry

From the Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund; and the Department of Clinical Immunology and Transfusion Medicine, University and Regional Laboratories Region Skåne, Lund, Sweden.

Search for more papers by this author
Martin L. Olsson

Martin L. Olsson

From the Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund; and the Department of Clinical Immunology and Transfusion Medicine, University and Regional Laboratories Region Skåne, Lund, Sweden.

Search for more papers by this author
First published: 10 February 2011
Citations: 27
Prof. Martin L Olsson, Clinical Immunology and Transfusion Medicine, University and Regional Laboratories, Akutgatan 8, SE-221 85, Lund, Sweden; e-mail: [email protected].

This work was supported in part by the Swedish Research Council (Project K2008-71X-14251), governmental ALF research grants to Lund University Hospital, the Medical Faculty at Lund University, Region Skåne, and the Vårdal Foundation.

Abstract

BACKGROUND: The clinically important Kidd (JK) blood group system is considered to be relatively uncomplicated, both serologically and genetically. The JK*01 and JK*02 alleles give rise to Jka and Jkb antigens, respectively, and silenced alleles result in Jk(a−b−). Other inherited variants analogous to Fyx and weak D phenotypes have not been characterized for JK, although recent abstracts indicate their presence.

STUDY DESIGN AND METHODS: Six index samples from individuals whose RBCs reacted variably or weakly with different sources of anti-Jka and 300 controls of the four known JK phenotypes were investigated by standard serology, flow cytometry, Western blotting, and the urea hemolysis test. Molecular analysis, including allele-specific polymerase chain reaction (PCR), DNA sequencing, and transcript analysis by real-time PCR, was performed.

RESULTS: All Jk(a+wb−) and Jk(a+wb+) index samples were homo- or heterozygous for an altered JK*01 allele carrying 130G>A (Glu44Lys) and the JK*02-associated silent SNPs 588G and Intron 9 –46g. Blood donor screening indicated an allele frequency of 0.042. Titration and flow cytometry with anti-Jka gave lower values in index samples compared to controls, as did anti-Jk3 titers. Donors with 130A also showed significantly decreased Jka density by flow cytometry versus 130G. Western blotting with anti-UT-B demonstrated weaker reactivity with Jk(a+w) membranes while JK mRNA levels could not discriminate index samples from controls. The urea hemolysis test was only moderately affected in two Jk(a+wb−) samples.

CONCLUSIONS: A new phenotype with weakened Jka expression on RBCs is associated with a JK*01-like allele, which may constitute a risk for hemolytic transfusion reactions if antigen-positive units are missed by routine serology.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.